Premium
Wild‐type LRRK2 as a new potential therapeutic target in idiopathic Parkinson's disease
Author(s) -
Sanjari Moghaddam Hossein,
Aarabi Mohammad Hadi
Publication year - 2018
Publication title -
movement disorders
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.352
H-Index - 198
eISSN - 1531-8257
pISSN - 0885-3185
DOI - 10.1002/mds.27509
Subject(s) - immunopharmacology , medical school , family medicine , medicine , neurology , christian ministry , medical education , psychiatry , political science , law , immune system , immunology